Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney patients needed to help Fine-Tune drug dosing

NCT ID NCT07137689

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times

Summary

This study looked at how the drug LY3537982 behaves in people with different levels of kidney function. Researchers gave a single dose to 32 participants with normal kidneys, moderate kidney problems, or severe kidney problems (not on dialysis). The goal was to see how kidney impairment changes drug levels in the blood, so doctors can choose the safest and most effective dose for these patients. The study lasted about 43 days per person.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Genesis Clinical Research

    Tampa, Florida, 33603, United States

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida, 32216, United States

  • Orlando Clinical Research Center

    Orlando, Florida, 32809, United States

  • Panax Clinical Research

    Miami Lakes, Florida, 33014, United States

Conditions

Explore the condition pages connected to this study.